Due to the wide impact of COVID-19 the state of the industry has fundamentally changed.
To keep the industry up to date and connected throughout these unprecedented times, we are introducing the AMR webinar series, where you will hear the industry’s leading figures tackle the industry's most critical topics, including advancing antibiotic R&D and non-traditional therapies development, enhancing the commercial landscape and marketplace for antibiotics and diagnostics, developing innovative diagnostics solutions much more.
Keeping Antimicrobial Resistance top-of-mind for policymakers and the public during COVID-19
Wednesday, June 17 2:30pm EDT
How can the AMR community leverage insights and lessons learned during COVID-19 to highlight the importance of having effective antibiotic treatments available in the future?
Join this interactive panel with journalists and antibiotic developers to discuss key issues facing the Antimicrobial Resistance community during this pandemic, including:
Current scientific understanding of Covid-19’s potential impact on resistance and use of antibiotics
Antibiotic marketplace and status of US legislation
Preparedness and implications for future outbreaks
US-based manufacturing and supply chain
Long-term impact of expertise leaving antibiotic development